广发生物科技指数人民币(QDII)C持股明细
| 股票名称 |
股票代码 |
股票数量（股） |
股票币值（元） |
占资产净值比例 |
| 再生元制药 |
REGN |
1666.0 |
11376891.67 |
7.71% |
| 安进 |
AMGN |
5088.0 |
10263770.04 |
6.95% |
| 福泰制药 |
VRTX |
3867.0 |
11468674.93 |
7.77% |
| Moderna Inc |
MRNA |
7284.0 |
5507018.67 |
3.73% |
| 阿斯利康(US ADR) |
AZN |
10621.0 |
5105368.66 |
3.46% |
| 吉利德科学 |
GILD |
17912.0 |
9309023.13 |
6.3% |
| Illumina Inc |
ILMN |
3033.0 |
2955007.62 |
2.0% |
| Alnylam Pharmaceuticals Inc |
ALNY |
2397.0 |
2541653.56 |
1.72% |
| 拜玛林制药 |
BMRN |
3598.0 |
2229598.93 |
1.51% |
| 生化基因 |
BIIB |
2768.0 |
4234748.94 |
2.87% |
| 福泰制药 |
VRTX |
3867.0 |
11144229.2 |
7.61% |
| 阿斯利康(US ADR) |
AZN |
10621.0 |
5066427.77 |
3.46% |
| 吉利德科学 |
GILD |
17912.0 |
10277359.77 |
7.02% |
| 再生元制药 |
REGN |
1666.0 |
10363627.2 |
7.08% |
| Moderna Inc |
MRNA |
7284.0 |
5130663.97 |
3.5% |
| Illumina Inc |
ILMN |
3033.0 |
2991129.88 |
2.04% |
| 安进 |
AMGN |
5088.0 |
10379312.68 |
7.09% |
| 拜玛林制药 |
BMRN |
3598.0 |
2457124.33 |
1.68% |
| Alnylam Pharmaceuticals Inc |
ALNY |
2397.0 |
3249611.96 |
2.22% |
| 生化基因 |
BIIB |
2768.0 |
5073163.49 |
3.47% |
| 吉利德科学 |
GILD |
18839.0 |
10136403.3 |
7.47% |
| Seagen Inc |
SGEN |
3294.0 |
5017402.91 |
3.7% |
| 生化基因 |
BIIB |
2536.0 |
4679631.09 |
3.45% |
| Moderna Inc |
MRNA |
6748.0 |
5004327.21 |
3.69% |
| 再生元制药 |
REGN |
1749.0 |
10334295.68 |
7.62% |
| Horizon Therapeutics plc |
HZNP |
4016.0 |
3335814.34 |
2.46% |
| 安进 |
AMGN |
5617.0 |
10838805.0 |
7.99% |
| 福泰制药 |
VRTX |
4124.0 |
10296405.86 |
7.59% |
| 阿斯利康(US ADR) |
AZN |
10303.0 |
5009484.02 |
3.69% |
| Alnylam Pharmaceuticals Inc |
ALNY |
2196.0 |
2792307.51 |
2.06% |
| 安进 |
AMGN |
6642.0 |
10655575.39 |
7.4% |
| 吉利德科学 |
GILD |
18897.0 |
10523595.8 |
7.31% |
| 福泰制药 |
VRTX |
4369.0 |
11109629.85 |
7.72% |
| 再生元制药 |
REGN |
1844.0 |
9574096.56 |
6.65% |
| 阿斯利康(US ADR) |
AZN |
9918.0 |
5129098.72 |
3.56% |
| Seagen Inc |
SGEN |
3204.0 |
4455730.61 |
3.1% |
| Moderna Inc |
MRNA |
6551.0 |
5751350.22 |
4.0% |
| Illumina Inc |
ILMN |
2665.0 |
3610449.37 |
2.51% |
| Alnylam Pharmaceuticals Inc |
ALNY |
2133.0 |
2927475.21 |
2.03% |
| 生化基因 |
BIIB |
2459.0 |
5061283.79 |
3.52% |
| 再生元制药 |
REGN |
2018.0 |
11394172.33 |
7.54% |
| 安进 |
AMGN |
5728.0 |
9515545.34 |
6.3% |
| 生化基因 |
BIIB |
2712.0 |
5181381.09 |
3.43% |
| 福泰制药 |
VRTX |
4812.0 |
10418300.09 |
6.9% |
| Moderna Inc |
MRNA |
7274.0 |
7676657.26 |
5.08% |
| 阿斯利康(US ADR) |
AZN |
11348.0 |
5412595.38 |
3.58% |
| Seagen Inc |
SGEN |
3495.0 |
4862639.28 |
3.22% |
| Alnylam Pharmaceuticals Inc |
ALNY |
2468.0 |
3397298.11 |
2.25% |
| Illumina Inc |
ILMN |
3026.0 |
4835589.86 |
3.2% |
| 吉利德科学 |
GILD |
18582.0 |
10594433.44 |
7.01% |
| Alnylam Pharmaceuticals Inc |
ALNY |
2700.0 |
4468870.41 |
2.49% |
| 再生元制药 |
REGN |
2344.0 |
11778340.41 |
6.55% |
| 福泰制药 |
VRTX |
5610.0 |
11283040.62 |
6.28% |
| 生化基因 |
BIIB |
3114.0 |
6005775.72 |
3.34% |
| Illumina Inc |
ILMN |
3482.0 |
4903499.06 |
2.73% |
| 安进 |
AMGN |
6630.0 |
12127480.27 |
6.75% |
| 阿斯利康(US ADR) |
AZN |
13274.0 |
6267981.21 |
3.49% |
| Moderna Inc |
MRNA |
8622.0 |
10785962.08 |
6.0% |
| 吉利德科学 |
GILD |
21524.0 |
12869434.43 |
7.16% |
| Horizon Therapeutics plc |
HZNP |
4900.0 |
3883600.25 |
2.16% |
| 安进 |
AMGN |
18997.0 |
30400802.6 |
6.29% |
| 吉利德科学 |
GILD |
75234.0 |
32951488.53 |
6.81% |
| Moderna Inc |
MRNA |
25646.0 |
21531133.92 |
4.45% |
| 福泰制药 |
VRTX |
16640.0 |
34206450.17 |
7.07% |
| 再生元制药 |
REGN |
7053.0 |
34495089.06 |
7.13% |
| 生化基因 |
BIIB |
9706.0 |
18399145.9 |
3.8% |
| Seagen Inc |
SGEN |
12016.0 |
11673131.06 |
2.41% |
| Alnylam Pharmaceuticals Inc |
ALNY |
7747.0 |
11009230.46 |
2.28% |
| 阿斯利康(US ADR) |
AZN |
36469.0 |
14199315.72 |
2.94% |
| Illumina Inc |
ILMN |
10059.0 |
13625628.1 |
2.82% |
